SCHEMBL7948437

SCHEMBL7948437

Bc1ccc2c(c1)C1(CC(c3cccc(OC)c3)O2)NC(=O)NC1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 5/20 0.41
AKR1B10 O60218 1/20 0.41
AKR1A1 P14550 1/20 0.41
LMNA P02545 1/20 0.40
ABCB1 P08183 1/20 0.38
AR P10275 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
CYP19A1 P11511 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
NFKB1 P19838 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7971361 0.90 LMNA (0.39) LMNAABCB1ARABCG2CYP19A1
SCHEMBL1819232 0.88 MEN1 (0.45) AKR1B1AKR1B10AKR1A1LMNAABCB1
SCHEMBL7956191 0.85 AKR1B1 (0.47) AKR1B1AKR1B10AKR1A1
SCHEMBL7956715 0.84 AKR1B1 (0.41) AKR1B1AKR1B10AKR1A1
SCHEMBL7957786 0.79 AKR1B1 (0.55) AKR1B1AKR1B10AKR1A1MAOB
SCHEMBL1824125 0.79 SMN1; SMN2 (0.44) AKR1B1LMNAABCB1ARABCG2
SCHEMBL7957860 0.76 AKR1B1 (0.48) AKR1B1AKR1B10AKR1A1KDM4EALDH1A1
SCHEMBL7957182 0.75 ALOX12 (0.39) AKR1B1AKR1B10AKR1A1ABCB1AR
SCHEMBL1823243 0.75 AKR1B1 (0.47) AKR1B1AKR1B10AKR1A1MAOB
SCHEMBL10576219 0.74 AKR1B1 (0.51) AKR1B1AKR1B10AKR1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010021680-A2 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, INC. (US) 2010-02-25 WO disclosed